2025-2031 Global Abaloparatide Injection Industry Research & Trends Analysis Report- YH Research

Home > Reports >Pharma & Healthcare > 2025-2031 Global Abaloparatide Injection Industry Research & Trends Analysis Report

2025-2031 Global Abaloparatide Injection Industry Research & Trends Analysis Report

Publication Date: 2025-12-12
Report Id: 2862884
Industry: Pharma & Healthcare
Report Page: 113
Chart: 115

PDF Download

Publication Date: 2025-12-12
Report Id: 2862884
Industry: Pharma & Healthcare
Report Page: 113
Chart: 115

PDF Download

A research report provider that focuses on identifying industry pain points and solving core problems for companies！

Table of Contents
Description
Table of Figures
Need a Quote?

1 Market Overview
1.1 Abaloparatide Injection Definition
1.2 Global Abaloparatide Injection Market Size and Forecast
1.2.1 By Revenue, Global Abaloparatide Injection Market Size, 2020-2031
1.2.2 By Sales Volume, Global Abaloparatide Injection Market Size, 2020-2031
1.2.3 Global Abaloparatide Injection Price Trend, 2020-2031
1.3 China Abaloparatide Injection Market Size and Forecast
1.3.1 By Revenue, China Abaloparatide Injection Market Size, 2020-2031
1.3.2 By Sales Volume, China Abaloparatide Injection Market Size, 2020-2031
1.3.3 China Abaloparatide Injection Price Trend, 2020-2031
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Abaloparatide Injection Share in Global Market, 2020-2031
1.4.2 By Sales Volume, China Abaloparatide Injection Share in Global Market, 2020-2031
1.4.3 Abaloparatide Injection Market Size: China VS Global, 2020-2031
1.5 Abaloparatide Injection Market Dynamics
1.5.1 Abaloparatide Injection Market Drivers
1.5.2 Abaloparatide Injection Market Restraints
1.5.3 Abaloparatide Injection Industry Trends
1.5.4 Abaloparatide Injection Industry Policy

2 Global Competitive Landscape by Company
2.1 Global Abaloparatide Injection Revenue by Company, 2020-2025
2.2 Global Abaloparatide Injection Sales Volume by Company, 2020-2025
2.3 Global Abaloparatide Injection Price by Company, 2020-2025
2.4 Global Abaloparatide Injection Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Abaloparatide Injection Concentration Ratio
2.6 Global Abaloparatide Injection Mergers & Acquisitions, Expansion Plans
2.7 Global Abaloparatide Injection Manufacturers Product Type

3 China Competitive Landscape by Company
3.1 China Abaloparatide Injection Revenue by Company, 2020-2025
3.2 China Abaloparatide Injection Sales Volume by Company, 2020-2025
3.3 China Abaloparatide Injection Abaloparatide Injection Participants, Market Position (Tier 1, Tier 2, and Tier 3)
3.4 China Abaloparatide Injection Market, Sales Percentage of Local Players VS Foreign Players (2020-2025)
3.5 Chinese Local Players, Abaloparatide Injection Domestic VS Export
3.6 China Market, Abaloparatide Injection Import & Export
3.6.1 China Market, Abaloparatide Injection Import & Export, 2020-2031
3.6.2 China Abaloparatide Injection Import & Export Trends
3.6.3 Main Sources of China Abaloparatide Injection Import
3.6.4 Export Destination of China Abaloparatide Injection

4 Abaloparatide Injection Production by Region
4.1 Global Abaloparatide Injection Capacity, Production and Capacity Utilization, 2020-2031
4.2 Global Geographic Distribution of Abaloparatide Injection Manufacturers
4.3 Global Major Manufacturers, Abaloparatide Injection Capacity Expansion and Future Plans
4.4 Global Abaloparatide Injection Capacity by Region
4.5 Global Abaloparatide Injection Production by Region
4.5.1 Global Abaloparatide Injection Production & Forecast by Region, 2020 VS 2024 VS 2031
4.5.2 Global Abaloparatide Injection Production by Region, 2020-2025
4.5.3 Global Abaloparatide Injection Production Market Share & Forecast by Region, 2020-2031

5 Industry Chain Analysis
5.1 Abaloparatide Injection Industry Chain
5.2 Abaloparatide Injection Upstream Analysis
5.2.1 Abaloparatide Injection Core Raw Materials
5.2.2 Main Manufacturers of Abaloparatide Injection Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Abaloparatide Injection Production Mode
5.6 Abaloparatide Injection Procurement Model
5.7 Abaloparatide Injection Industry Sales Model and Sales Channels
5.7.1 Abaloparatide Injection Sales Model
5.7.2 Abaloparatide Injection Typical Distributors

6 Sights by Type
6.1 Abaloparatide Injection Classification by Type
6.1.1 Prefilled Pens
6.1.2 Others
6.2 by Type, Global Abaloparatide Injection Market Size & CAGR, 2020 VS 2024 VS 2031
6.3 by Type, Global Abaloparatide Injection Revenue, 2020-2031
6.4 by Type, Global Abaloparatide Injection Sales Volume, 2020-2031
6.5 by Type, Global Abaloparatide Injection Price, 2020-2031

7 Sights by Sales Channels
7.1 Abaloparatide Injection Classification by Sales Channels
7.1.1 Online Sales
7.1.2 Offline Sales
7.2 by Sales Channels, Global Abaloparatide Injection Market Size & CAGR, 2020 VS 2024 VS 2031
7.3 by Sales Channels, Global Abaloparatide Injection Revenue, 2020-2031
7.4 by Sales Channels, Global Abaloparatide Injection Sales Volume, 2020-2031
7.5 by Sales Channels, Global Abaloparatide Injection Price, 2020-2031

8 Sights by Patient
8.1 Abaloparatide Injection Classification by Patient
8.1.1 Male
8.1.2 Female
8.2 by Patient, Global Abaloparatide Injection Market Size & CAGR, 2020 VS 2024 VS 2031
8.3 by Patient, Global Abaloparatide Injection Revenue, 2020-2031
8.4 by Patient, Global Abaloparatide Injection Sales Volume, 2020-2031
8.5 by Patient, Global Abaloparatide Injection Price, 2020-2031

9 Sights by Application
9.1 Abaloparatide Injection Segment by Application
9.1.1 Hospital
9.1.2 Clinic
9.1.3 Other
9.2 by Application, Global Abaloparatide Injection Market Size & CAGR, 2020 VS 2024 VS 2031
9.3 by Application, Global Abaloparatide Injection Revenue, 2020-2031
9.4 by Application, Global Abaloparatide Injection Sales Volume, 2020-2031
9.5 by Application, Global Abaloparatide Injection Price, 2020-2031

10 Sales Sights by Region
10.1 By Region, Global Abaloparatide Injection Market Size, 2020 VS 2024 VS 2031
10.2 By Region, Global Abaloparatide Injection Revenue, 2020-2031
10.3 By Region, Global Abaloparatide Injection Sales Volume, 2020-2031
10.4 North America
10.4.1 North America Abaloparatide Injection Market Size & Forecasts, 2020-2031
10.4.2 By Country, North America Abaloparatide Injection Market Size Market Share
10.5 Europe
10.5.1 Europe Abaloparatide Injection Market Size & Forecasts, 2020-2031
10.5.2 By Country, Europe Abaloparatide Injection Market Size Market Share
10.6 Asia Pacific
10.6.1 Asia Pacific Abaloparatide Injection Market Size & Forecasts, 2020-2031
10.6.2 By Country/Region, Asia Pacific Abaloparatide Injection Market Size Market Share
10.7 South America
10.7.1 South AmericaAbaloparatide Injection Market Size & Forecasts, 2020-2031
10.7.2 By Country, South America Abaloparatide Injection Market Size Market Share
10.8 Middle East & Africa

11 Sales Sights by Country Level
11.1 By Country, Global Abaloparatide Injection Market Size & CAGR，2020 VS 2024 VS 2031
11.2 By Country, Global Abaloparatide Injection Revenue, 2020-2031
11.3 By Country, Global Abaloparatide Injection Sales Volume, 2020-2031
11.4 United States
11.4.1 United States Abaloparatide Injection Market Size, 2020-2031
11.4.2 By Company, United States Abaloparatide Injection Sales Volume Market Share, 2024
11.4.3 by Type, United States Abaloparatide Injection Market Size, Share, 2024 VS 2031
11.4.4 by Application, United States Abaloparatide Injection Market Size, Share, 2024 VS 2031
11.5 Europe
11.5.1 Europe Abaloparatide Injection Market Size, 2020-2031
11.5.2 By Company, Europe Abaloparatide Injection Sales Volume Market Share, 2024
11.5.3 by Type, Europe Abaloparatide Injection Market Size, Share, 2024 VS 2031
11.5.4 by Application, Europe Abaloparatide Injection Market Size, Share, 2024 VS 2031
11.6 China
11.6.1 China Abaloparatide Injection Market Size, 2020-2031
11.6.2 By Company, China Abaloparatide Injection Sales Volume Market Share, 2024
11.6.3 by Type, China Abaloparatide Injection Market Size, Share, 2024 VS 2031
11.6.4 by Application, China Abaloparatide Injection Market Size, Share, 2024 VS 2031
11.7 Japan
11.7.1 Japan Abaloparatide Injection Market Size, 2020-2031
11.7.2 By Company, Japan Abaloparatide Injection Market Share, 2024
11.7.3 by Type, Japan Abaloparatide Injection Market Size, Share, 2024 VS 2031
11.7.4 by Application, Japan Abaloparatide Injection Market Size, Share, 2024 VS 2031
11.8 South Korea
11.8.1 South Korea Abaloparatide Injection Market Size, 2020-2031
11.8.2 By Company, South Korea Abaloparatide Injection Market Share, 2024
11.8.3 by Type, South Korea Abaloparatide Injection Market Size, Share, 2024 VS 2031
11.8.4 by Application, South Korea Abaloparatide Injection Market Size, Share, 2024 VS 2031
11.9 Southeast Asia
11.9.1 Southeast Asia Abaloparatide Injection Market Size, 2020-2031
11.9.2 By Company, Southeast Asia Abaloparatide Injection Market Share, 2024
11.9.3 by Type, Southeast Asia Abaloparatide Injection Market Size, Share, 2024 VS 2031
11.9.4 by Application, Southeast Asia Abaloparatide Injection Market Size, Share, 2024 VS 2031
11.10 India
11.10.1 India Abaloparatide Injection Market Size, 2020-2031
11.10.2 By Company, India Abaloparatide Injection Market Share, 2024
11.10.3 by Type, India Abaloparatide Injection Market Size, Share, 2024 VS 2031
11.10.4 by Application, India Abaloparatide Injection Market Size, Share, 2024 VS 2031
11.11 Middle East & Africa
11.11.1 Middle East & Africa Abaloparatide Injection Market Size, 2020-2031
11.11.2 By Company, Middle East & Africa Abaloparatide Injection Market Share, 2024
11.11.3 by Type, Middle East & Africa Abaloparatide Injection Market Size, Share, 2024 VS 2031
11.11.4 by Application, Middle East & Africa Abaloparatide Injection Market Size, Share, 2024 VS 2031

12 Manufacturers Profile
12.1 Radius Pharmaceuticals
12.1.1 Radius Pharmaceuticals Company Information, Head Office, Market Area, and Industry Position
12.1.2 Radius Pharmaceuticals Abaloparatide Injection Models, Specifications, and Application
12.1.3 Radius Pharmaceuticals Abaloparatide Injection Sales Volume, Revenue, Price and Gross Margin, 2020-2025
12.1.4 Radius Pharmaceuticals Company Profile and Main Business
12.1.5 Radius Pharmaceuticals Recent Developments
12.2 Theramex
12.2.1 Theramex Company Information, Head Office, Market Area, and Industry Position
12.2.2 Theramex Abaloparatide Injection Models, Specifications, and Application
12.2.3 Theramex Abaloparatide Injection Sales Volume, Revenue, Price and Gross Margin, 2020-2025
12.2.4 Theramex Company Profile and Main Business
12.2.5 Theramex Recent Developments
12.3 Pharmanovia
12.3.1 Pharmanovia Company Information, Head Office, Market Area, and Industry Position
12.3.2 Pharmanovia Abaloparatide Injection Models, Specifications, and Application
12.3.3 Pharmanovia Abaloparatide Injection Sales Volume, Revenue, Price and Gross Margin, 2020-2025
12.3.4 Pharmanovia Company Profile and Main Business
12.3.5 Pharmanovia Recent Developments

13 Conclusion

14 Appendix
14.1 Research Methodology
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Market Estimation Model
14.4 Disclaimer

According to YH Research, the global market for Abaloparatide Injection should grow from US$ 376 million in 2024 to US$ 532 million by 2031, with a CAGR of 5.3% for the period of 2025-2031.

The strategic recalibration of 2025 U.S. tariff mechanisms is redefining global economic governance norms. This study deciphers the transmission mechanisms of tariff escalation pathways and global policy responses on corporate investment strategies, regional trade networks, and critical material supply architectures.

Abaloparatide Injection

According to YH Research, the global market for Abaloparatide Injection should grow from US$ 376 million in 2024 to US$ 532 million by 2031, with a CAGR of 5.3% for the period of 2025-2031.

Unit: US$ M

www.yhresearch.com

In-depth insight into market trends

Abaloparatide Injection was approved by the U.S. FDA in April 2017 for the treatment of postmenopausal women with osteoporosis at high risk of fracture, and in December 2022, its indication was expanded to include men with osteoporosis at high risk of fracture to increase bone density. The injection is a prescription formulation produced as lyophilized vials or prefilled pens using high-purity abaloparatide peptide API and injectable excipients. Its manufacturing heavily relies on GMP-grade peptide raw materials, injectable-grade solvents, buffers, and stabilizers, coupled with high-standard lyophilization, aseptic filling, and rigorous quality control to ensure product purity, stability, and safety. In 2024, global production capacity is approximately 200,000 units, with sales of around 136,000 units, an average price of USD 2,600 per unit, and gross margins of 42%–58%, with profitability strongly influenced by production efficiency, raw material costs, and supply reliability. Downstream customers include hospitals, pharmaceutical wholesalers and distributors, reimbursement procurement platforms, long-acting bone health management programs, and clinical research institutions.

The current market for Abaloparatide Injection is characterized by concentrated demand among postmenopausal osteoporosis patients and individuals at high risk of fractures, with supply dominated by a limited number of manufacturers possessing advanced peptide production and aseptic filling capabilities. Downstream clients include hospitals, pharmaceutical distributors, reimbursement procurement platforms, long-acting bone health programs, and clinical research institutions, all of which place stringent requirements on product purity, stability, supply reliability, and GMP compliance. In recent years, the industry has exhibited steady growth, driven by increased patient awareness of bone health and the gradual expansion of healthcare coverage for osteoporosis therapies.

Future development trends are emerging in three main areas. First, long-acting and non-injectable delivery modalities are becoming R&D priorities, including microspheres, implants, transdermal patches, and nasal formulations, aimed at improving patient adherence and expanding treatment scenarios. Second, production processes and technologies continue to evolve, encompassing scale-up of solid-phase peptide synthesis, improved purification efficiency, and solvent replacement strategies, all of which reduce production costs and environmental impact. Third, the maturation of regional regulations and improved reimbursement accessibility in emerging markets accelerate product market entry and broaden the commercial landscape to include outpatient management and chronic disease prevention frameworks.

Market growth is primarily driven by increased clinical demand from aging populations, expanded reimbursement and affordability, and heightened patient focus on adherence and long-term bone health management. At the same time, technological innovation continues to enable the industrialization of novel delivery platforms and long-acting formulations, allowing companies to differentiate and meet the diverse needs of downstream stakeholders.

However, the market faces several challenges. The production of peptide-based APIs and injectable formulations is cost-intensive, technically complex, and demands high-quality raw materials and equipment, creating operational pressures for manufacturers. Regulatory and filing requirements vary significantly across countries, with uncertain approval timelines for DMF/CEP submissions, which can delay market entry. Additionally, payer cost-containment policies and pricing pressures may limit long-term market expansion, while patient awareness and physician prescribing habits require time to develop. Overall, the Abaloparatide Injection market operates within a dynamic environment shaped by policy, technology, and commercial model factors, presenting both opportunities and challenges.

This report aims to provide a comprehensive study of the global market for Abaloparatide Injection. 
Report Highlights:
(1) Global Abaloparatide Injection market size (sales volume & revenue), history data from 2020-2025, and forecast data from 2026 to 2031.

(2) Global Abaloparatide Injection market competitive situation, sales, revenue, price, and market share, from 2020 to 2025.

(3) China Abaloparatide Injection market competitive situation, sales, revenue, price, and market share, from 2020 to 2025.

(4) Global Abaloparatide Injection segment by region (or country), key regions cover the United States, Europe, China, Japan, South Korea, Southeast Asia, and India, etc.

(5) Global Abaloparatide Injection segment by Type, and by Application, and regional segment by Type, and by Application.

(6) Global major production regions of Abaloparatide Injection, capacity, production and trends.

(7) Abaloparatide Injection industry supply chain, upstream, midstream, and downstream analysis.

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by Type, covers
    Prefilled Pens
    Others

Market segment by Sales Channels, covers
    Online Sales
    Offline Sales

Market segment by Patient, covers
    Male
    Female

Market segment by Application, can be divided into
    Hospital
    Clinic
    Other

Market segment by players, this report covers
    Radius Pharmaceuticals
    Theramex
    Pharmanovia